| Formulary Chapter 14: Immunological products and vaccines - Full Chapter
|
| Chapter Links... |
 HPA: Vaccine incident guidance (actions to take in response to vaccine errors) |
| MHRA: Live attenuated vaccines - Avoid use in those who are clinically immunosuppressed |
| Public Health England: Splenectomy, leaflet for patients |
| Public Health England: Splenectomy, patient alert card |
 Routine immunisation schedule from summer 2016 |
| The DoH Green book on Immunisation against infectious disease |
| Details... |
| 14.04 |
Vaccines and antisera |
|
|
| 14.04 |
Anthrax vaccine |
|
|
| 14.04 |
BCG vaccines |
|
|
| 14.04 |
Botulism antitoxin |
|
|
| 14.04 |
Cholera vaccine |
|
|
| 14.04 |
Diphtheria vaccines |
|
|
| 14.04 |
Haemophilus influenzae type B vaccine |
|
|
| 14.04 |
Hepatitis A vaccine |
|
|
Hepatitis A vaccine Single Component (Avaxim®)
|
Formulary
|
|
Hepatitis A: the green book, chapter 17
|
Hepatitis A vaccine Single Component (Epaxal®)
|
Formulary
|
|
Hepatitis A: the green book, chapter 17
|
Hepatitis A vaccine Single Component (Havrix Monodose®)
|
Formulary
|
|
Hepatitis A: the green book, chapter 17
|
Hepatitis A vaccine Single Component (Vaqta® Paediatric)
|
Formulary
|
|
Hepatitis A: the green book, chapter 17
|
| 14.04 |
Hepatitis B vaccine |
|
|
| 14.04 |
Human papilloma virus vaccine |
|
|
| 14.04 |
Influenza vaccine |
|
|
| 14.04 |
Measles vaccine |
|
|
| 14.04 |
Measles, Mumps and Rubella (MMR) vaccine |
|
|
| 14.04 |
Meningococcal vaccines |
|
|
| 14.04 |
Mumps vaccine |
|
|
| 14.04 |
Pertussis vaccine |
|
|
| 14.04 |
Pneumococcal vaccines |
|
|
| 14.04 |
Poliomyelitis vaccines |
|
|
| 14.04 |
Rabies vaccine |
|
|
| 14.04 |
Rotavirus vaccine |
|
|
| 14.04 |
Rubella vaccine |
|
|
| 14.04 |
Smallpox vaccine |
|
|
| 14.04 |
Tetanus vaccines |
|
|
| 14.04 |
Tick-borne encephalitis vaccine |
|
|
| 14.04 |
Typhoid vaccines |
|
|
| 14.04 |
Varicella-zoster vaccine |
|
|
| 14.04 |
Yellow fever vaccine |
|
|
| .... |
| Non Formulary Items |
Hepatitis A vaccine with Hepatitis B vaccine (Twinrix®, Ambirix®)
|
Non Formulary
|
 Hepatitis B vaccine is not funded by NHS for travel purposes.
APCO May 2017. |
Hepatitis A: the green book, chapter 17
Hepatitis B: the green book, chapter 18
|
Hepatitis A vaccine with typhoid vaccine (Hepatyrix®)
|
Non Formulary
|
Prescribing Hep A and typhoid separately is more cost-effective. APCO May 2017. |
Hepatitis A: the green book, chapter 17
Typhoid: the green book, chapter 33
|
Hepatitis A vaccine with typhoid vaccine (ViATIM®)
|
Non Formulary
|
Prescribing Hep A and typhoid separately is more cost-effective. APCO May 2017. |
Hepatitis A: the green book, chapter 17
Typhoid: the green book, chapter 33
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Red: Medicines which should only be prescribed in secondary care by a specialist. |
|
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred. |
|
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO). |
|
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care. |
|
Brown: Medicines which should only be prescribed in restricted circumstances. |
|
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety. |
|
not used |
|
|
|
